title: Combined lamivudine and interferon-alpha therapy for chemotherapy-induced reactivation of hepatitis B virus.
authors.forename: Kenji
authors.initials: K
authors.lastname: Ohmoto
authors.forename: Masayuki
authors.initials: M
authors.lastname: Tsuduki
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Yamamoto
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects*; D006509:Hepatitis B / Q000188:drug therapy* / Q000821:virology; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D011241:Prednisone / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014750:Vincristine / Q000009:adverse effects*; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D016898:Interferon-alpha; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone